FDA Drug Application (012928) for NOVRAD by LILLY

Back to FDA Applications sponsored by LILLY

Application Number012928
Product Number002
FormSUSPENSION;ORAL
DosageEQ 50MG BASE/5ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNOVRAD
Active IngredientLEVOPROPOXYPHENE NAPSYLATE ANHYDROUS



Back to FDA Applications sponsored by LILLY